Orexigen

2013 Press Releases

Print Page |  E-mail Page |  RSS Feeds |  E-mail Alerts |  Financial Tear Sheet

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009

Date Title   05/17/13 Orexigen Therapeutics to Present at the UBS Global Healthcare Conference 05/10/13 Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference 05/08/13 Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013 05/02/13 Orexigen Therapeutics to Host First Quarter 2013 Financial Results Conference Call and Webcast 04/25/13 Orexigen Therapeutics Commends the Campaign to End Obesity's Report on Long-term Returns of Obesity Prevention Policies 04/22/13 Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors 03/13/13 Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012 03/07/13 Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast 02/28/13 Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference 02/07/13 Orexigen Therapeutics to Present at Upcoming Investor Conferences 01/07/13 Orexigen Therapeutics Announces Progress with FDA on a Faster Path to Resubmission of the Contrave NDA